Revance Therapeutics, Inc. 10-K, 10-K/A, and 10-KT reports

Location
1222 Demonbreun Street, Suite 2000, Nashville, Tennessee
State of incorporation
Delaware
Fiscal year end
December 31
Data updated at
5/10/2024, 04:16 AM
Form type Sec Links Description Filing date Reporting date
10-K Report | Data 10-K Feb 28, 2024 Dec 31, 2023
10-K Report | Data 10-K Feb 28, 2023 Dec 31, 2022
10-K Report | Data 10-K Feb 28, 2022 Dec 31, 2021
10-K Report | Data 10-K Feb 25, 2021 Dec 31, 2020
10-K Report | Data 10-K Feb 26, 2020 Dec 31, 2019
10-K Report | Data 10-K Feb 28, 2019 Dec 31, 2018
10-K Report | Data 10-K Mar 2, 2018 Dec 31, 2017
10-K Report | Data 10-K Feb 28, 2017 Dec 31, 2016
10-K Report | Data 10-K Mar 4, 2016 Dec 31, 2015
10-K Report | Data 10-K Mar 4, 2015 Dec 31, 2014
10-K Report 10-K Mar 28, 2014 Dec 31, 2013